HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Riboflavin-UVA treatment in the management of edema and nonhealing ulcers of the cornea.

AbstractPURPOSE:
Riboflavin-ultraviolet A (UVA) treatment induces cross-linking and stiffens the corneal stroma. A parallel reduction in stromal swelling and increased resistance to microbial and enzymatic degradation has been suggested. The purpose of this study was to evaluate the potential of riboflavin-UVA treatment in the management of corneal disorders, in particular edema due to endothelial decompensation and non-healing ulcers.
METHODS:
Two clinical series are reported, 11 eyes with endothelial decompensation and 14 eyes with non-healing ulcers. Treatment comprised a) abrasion of epithelium (if present), b) instillation of 0.1% riboflavin in saline, and c) irradiation at 365 nm UVA light over approximately 30 minutes (3 mW/cm(2)). Four eyes in the first group were treated twice. Postoperatively, all eyes were followed for at least 3 months.
RESULTS:
Reduction in corneal thickness was observed in 10 of 11 eyes with stromal edema and the majority also experienced improvement in vision. The effect occurred over weeks and lasted for months. Fourteen patients with non-healing ulceration were similarly treated; 6 healed, 8 showed no clear effect.
CONCLUSIONS:
In addition to the stiffening of keratoconic and ectatic cornea, riboflavin-UVA treatment is effective in reducing corneal edema and has the potential to heal corneal ulcers.
AuthorsNiels Ehlers, Jesper Hjortdal, Kim Nielsen, Anders Søndergaard
JournalJournal of refractive surgery (Thorofare, N.J. : 1995) (J Refract Surg) Vol. 25 Issue 9 Pg. S803-6 (Sep 2009) ISSN: 1081-597X [Print] United States
PMID19772255 (Publication Type: Journal Article)
CopyrightCopyright 2009, SLACK Incorporated.
Chemical References
  • Photosensitizing Agents
  • Collagen
  • Riboflavin
Topics
  • Aged
  • Aged, 80 and over
  • Collagen (metabolism)
  • Corneal Edema (drug therapy, pathology)
  • Corneal Stroma (metabolism, pathology)
  • Corneal Ulcer (drug therapy, pathology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Photochemotherapy
  • Photosensitizing Agents (therapeutic use)
  • Riboflavin (therapeutic use)
  • Ultraviolet Rays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: